Blue Venture Fund backs Daymark Health

Daymark Health raised $20 million in Series A funding led by Healthier Capital with Blue Venture Fund , alongside Yosemite, Maverick Ventures, and Oncology Ventures. This round brings the company’s total funding to over $57 million.

Based in Philadelphia, Daymark (team of ~30) partners with health plans to deliver cancer care that extends beyond the clinic, combining virtual and in-home services. Its platform connects patients with community-based clinicians who provide navigation, 24/7 support, symptom management, mental health assistance, and social services. By aligning with payers and providers, Daymark aims to improve outcomes and manage the rising costs of oncology care. The new capital will support expansion of its tech-enabled platform to more patients and health plan partners nationwide.

“Daymark is breaking down the silos in healthcare delivery to better enable personalized care for patients with cancer, while improving outcomes and reducing avoidable costs. Daymark is delivering a transformational model of personalized, high-quality, value-based cancer care.” – Aman Mahajan, MD, PhD, Partner at Healthier Capital.